Contact Us
 • 
Home
Search 

Clinical Trials > CiPHER  

  • Information
CiPHER   

Title

Phase II multicentre study assessing the efficacy of Cabazitaxel in Patients with HER2-negative metastatic breast cancer and having unresectable brain metastases


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
II Treatment Open Clatterbridge Centre for Oncology NHS Foundation Trust Eudract No: 2012-000542-35 15

Trial Start Date

10/10/2014


Trial Coordinator

Helen Scott


Trial Coordinator Email Address

hscott@liv.ac.uk


Trial Coordinator Contact No

0151 794 8209